![]() Once generics hit the market, Hugin said, the price of name-brand drugs "are going to near zero," while the public continues to benefit from their discoveries for decades to come. Senate race update: Groups that take unlimited cash get nasty early in Menendez-Hugin raceĦ months down: Phil Murphy still learning how to win friends and influence lawmakersĬompanies that develop drugs, Hugin says, need to be able to recoup their investments, fund research into new treatments and make a profit while they have commercial protection from competition. In 2016, I think, pharmaceutical expenditures went up 1.6 percent, co-pays went up 30 percent." "Over the last three or four years, copays and coinsurance have risen. "We have allowed plan design to put the burden on patients unfairly," Hugin said. All taxpayers end up paying more in that case." "The way drug benefits work in Medicare Part D, the higher the drug price, the faster you get to the point where Medicare pays more. They pay close to $1,000 a month for one set of pills, and they need to take it for the rest of their life," Dusetzina said. "People who need to take the drug, a lot of them are on Medicare. The company cut the price of Revlimid by 45 percent last year in Russia at the same time it raised prices 20 percent in the United States, NJ Advance Media reported on Sunday. ![]() Since Revlimid was approved in 2005, she said, the cost of a 30-day supply grew from about $8,000 to $19,000. "Revlimid is a very good example people pull out when pointing to problems with changes in drug prices," said Stacie Dusetzina, a health policy expert at Vanderbilt University Medical Center. ![]() The New Jersey Globe first reported Hugin’s likely ascent to the post on Wednesday.Celgene makes several drugs to treat cancer, including Revlimid, which treats a type of blood cancer called multiple myeloma. Incumbent Ileana Schirmer leads Trenton GOP Municipal Chair Jennifer Williams by 184 votes. There are clear winners in 41 races for State Committee, although one seat in Mercer County, is too close to call. Phil Murphy signs a bill approved by the legislature last week with bi-partisan support that pushes party reorganization meetings until after the results are certified on June 22. “I am confident that through Bob’s strong leadership, the Republican Party in New Jersey will continue to build, grow, and expand so that we can provide our candidates with the knowledge, tools and resources to be successful in 2021 and beyond.”Ī reorganization meeting is set for June 15. “I am happy to endorse Bob Hugin to be my successor as Chairman of the New Jersey Republican State Committee, and I encourage all of our Committee members to support him not only at our June 15th meeting but in the years to come,” said Lavery. Lavery, an ally of former GOP State Chairman Doug Steinhardt, will leave office once the Republican State Committee formally votes Hugin in. In a race he didn’t enter until the day before the vote, Michael Lavery beat him by six votes, 24 to 18. Senate in 2018, will get the post he sought last December. Hugin, a former Celgene CEO who spent $36 million of his own money in a bid for U.S. ![]() Press play to hear a narrated version of this story, presented by AudioHopper. Bob can help us do that up and down the ticket.” “I am proud to have Bob as a member of this team and look forward to seeing the incredible momentum and success that we can accomplish together. His fundraising capability, organizational skills, and proven leadership qualities will usher in a new era for the Republican Party in New Jersey,” Ciattarelli said. “Bob Hugin is a self-made successful businessman, Marine Corps veteran, and the best possible leader for the NJGOP at this time. Republican gubernatorial candidate Jack Ciattarelli today endorsed Bob Hugin as his pick for GOP State Chairman.īy tradition, the party’s nominee for governor gets to designate the new state chairman. ![]()
0 Comments
Leave a Reply. |